Comment on the Updated AASLD Practice Guidelines for the Diagnosis, Management, and Treatment of Hepatitis C: Treating Active Drug Users

被引：8
|
作者：
Swan, Tracy [1 ]
Curry, Jen [2 ]
机构：
[1] Treatment Act Grp, New York, NY USA
[2] Harm Reduct Coalit, Oakland, CA USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 01期
关键词：
VIRUS-INFECTION; OUTCOMES; THERAPY; MODEL;
D O I：
10.1002/hep.23077
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：323 / 324
页数：2
相关论文
共 50 条
  • [21] Treatment costs of hepatitis C infection among injection drug users in Canada, 2006-2026
    Werb, Daniel
    Wood, Evan
    Kerr, Thomas
    Hershfield, Neil
    Palmer, Robert W. H.
    Remis, Robert S.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2011, 22 (01) : 70 - 76
  • [22] Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the netherlands
    Schreuder, Imke
    van der Sande, Marianne A. B.
    de Wit, Matty
    Bongaerts, Monique
    Boucher, Charles A. B.
    Croes, Esther A.
    van Veen, Maaike G.
    HARM REDUCTION JOURNAL, 2010, 7
  • [23] Reducing Barriers to Hepatitis C Treatment among Drug Users: An Integrated Hepatitis C Peer Education and Support Program
    Roose, Robert J.
    Cockerham-Colas, Lauren
    Soloway, Irene
    Batchelder, Abigail
    Litwin, Alain H.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2014, 25 (02) : 652 - 662
  • [24] Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection
    Dore, Gregory J.
    Hellard, Margaret
    Matthews, Gail V.
    Grebely, Jason
    Haber, Paul S.
    Petoumenos, Kathy
    Yeung, Barbara
    Marks, Philippa
    van Beek, Ingrid
    McCaughan, Geoffrey
    White, Peter
    French, Rosemary
    Rawlinson, William
    Lloyd, Andrew R.
    Kaldor, John M.
    GASTROENTEROLOGY, 2010, 138 (01) : 123 - 135
  • [25] Optimal Control of Hepatitis C Antiviral Treatment Programme Delivery for Prevention amongst a Population of Injecting Drug Users
    Martin, Natasha K.
    Pitcher, Ashley B.
    Vickerman, Peter
    Vassall, Anna
    Hickman, Matthew
    PLOS ONE, 2011, 6 (08):
  • [26] Utility of the Beck Depression Inventory to screen for and track depression in injection drug users seeking hepatitis C treatment
    Holtzheimer, Paul E.
    Veitengmber, Jason
    Wang, Chia C.
    Krows, Meighan
    Thiede, Hanne
    Wald, Anna
    Roy-Byrne, Peter
    GENERAL HOSPITAL PSYCHIATRY, 2010, 32 (04) : 426 - 432
  • [27] Injection behaviors among injection drug users in treatment: The role of hepatitis C awareness
    Korthuis, P. Todd
    Feaster, Daniel J.
    Gomez, Zoilyn L.
    Das, Moupali
    Tross, Susan
    Wiest, Katharina
    Douaihy, Antoine
    Mandler, Raul N.
    Sorensen, James L.
    Colfax, Grant
    McCarty, Dennis
    Cohen, Stephanie E.
    Penn, Patricia E.
    Lape, Diane
    Metsch, Lisa R.
    ADDICTIVE BEHAVIORS, 2012, 37 (04) : 552 - 555
  • [28] Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia
    Vicknasingam, Balasingam
    Narayanan, Suresh
    Navaratnam, Visweswaran
    DRUG AND ALCOHOL REVIEW, 2009, 28 (04) : 447 - 454
  • [29] Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre
    Islam, M. Mofizul
    Topp, Libby
    Conigrave, Katherine M.
    White, Ann
    Reid, Sharon E.
    Grummett, Sara
    Haber, Paul S.
    Day, Carolyn A.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2012, 43 (04) : 440 - 445
  • [30] Effectiveness and Tolerability of Combination Treatment of Chronic Hepatitis C in Illicit Drug Users: Meta-Analysis of Prospective Studies
    Zanini, Barbara
    Covolo, Loredana
    Donato, Francesco
    Lanzini, Alberto
    CLINICAL THERAPEUTICS, 2010, 32 (13) : 2139 - 2159
12345